Patient Education in NorthTrondelag Hospital Trust

Not Applicable

Completed

• Conditions: Diabetes Mellitus

• Registration Number: NCT00326222
• Lead Sponsor: Norwegian University of Science and Technology

Brief Summary

The purpose of this randomised open study is to examine the effect of self-management program for diabetes patients.

Detailed Description

The primary aim in this study is HbA1c in addition to secondary aims like quality of life and coping.

Study Timeline

• Study Start: 2006-05
• Study First Submitted: 2006-05-15
• Study First Submitted QC: 2006-05-15
• Study First Posted: 2006-05-16
• Primary Completion: 2008-11
• Study Completion: 2008-11
• Status Verified: 2016-07
• Last Update Submitted: 2016-07-18
• Last Update Posted: 2016-07-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 146

Inclusion Criteria

• Diagnosed with ICPC-2, code T89 - diabetes dependent on insulin and T90 diabetes not dependent on insulin

Exclusion Criteria

• Diagnosed with ICPC-2, code T89 - diabetes mellitus juvenile and diabetes I
• Attended self-management program previous 12 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
PAM - Patient activation measure	Baseline, 6, and 12 mds
HbA1c	Baseline, 6, and 12 mds

Secondary Outcome Measures

Name	Time	Method
SF36	Baseline, 6, and 12 mds
Hunt diabetes	Baseline, 6, and 12 mds
Knowledge of diabetes	Baseline, 6, and 12 mds
Cost/benefit	Baseline, 6, and 12 mds
Triglyceride	Baseline, 6, and 12 mds
WHO-DTSQ	Baseline, 6, and 12 mds
HDL-cholesterol	Baseline, 6, and 12 mds
Creatinin	Baseline, 6, and 12 mds
Blood pressure	Baseline, 6, and 12 mds
BMI	Baseline, 6, and 12 mds
Total cholesterol	Baseline, 6, and 12 mds
Weight	Baseline, 6, and 12 mds
EQ 5D-VAS scale	Baseline, 6, and 12 mds

Trial Locations

Locations (1)

Nord-Trondelag Hospital Trust; 🇳🇴 Levanger, Nord-Trondelag, Norway